TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2‐mediated degradation
Sign Up to like & getrecommendations! Published in 2022 at "EMBO reports"
DOI: 10.15252/embr.202153468
Abstract: Androgen receptor (AR) is a master transcription factor that drives prostate cancer (PCa) development and progression. Alterations in the expression or activity of AR coregulators significantly impact the outcome of the disease. Using a proteomics… read more here.
Keywords: tumor growth; skp2 mediated; drives prostate; trim33 ... See more keywords